4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-018509
Chief Financial Officer sold 12,823 shares at $15.55 ($199,335)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2022-03-10 | Sale | −12,823 | $15.55 | $199,335 | 201,883 | D: show line 1 in the form |
| Open-market sales · 12,823 sh · avg $15.55 · $199,335 | |||||||
Loading xslF345X03/doc4.xml…